4D Molecular Therapeutics, Inc.
NASDAQ:FDMTBiotechnology
Healthcare
$10.79 +1.70%
+$0.16 today
- Market cap
- $596.08M
- Beta
- 2.76
- P/E (TTM)
- -4.0
- EPS (TTM)
- -$2.36
52W Low $3.68High $12.34
Volume 0.81M
Average 0.77M
Price history
4D Molecular Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+6.94%
Period high
$16.76
Period low
$7.19
Latest
$10.79
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Nov 12, 2026 | Nov 12, 2026 | |
| 10-Q | Nov 12, 2026 | Nov 12, 2026 | |
| SC 13G | Nov 10, 2026 | Nov 10, 2026 | |
| 4 | Oct 20, 2026 | Oct 20, 2026 | |
| 4 | Oct 7, 2026 | Oct 7, 2026 | |
| 8-K | Sep 28, 2026 | Sep 28, 2026 | |
| 4 | Sep 22, 2026 | Sep 22, 2026 | |
| 4 | Sep 16, 2026 | Sep 16, 2026 | |
| 4 | Sep 3, 2026 | Sep 3, 2026 | |
| 4 | Aug 21, 2026 | Aug 21, 2026 | |
| 4 | Aug 17, 2026 | Aug 17, 2026 | |
| 8-K | Aug 13, 2026 | Aug 13, 2026 | |
| 10-Q | Aug 13, 2026 | Aug 13, 2026 | |
| 4 | Aug 5, 2026 | Aug 5, 2026 | |
| 4 | Aug 4, 2026 | Aug 4, 2026 |
Competitors
Who does 4D Molecular Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about FDMT's filings, answered from its disclosures.
What is the latest FDMT filing?
The latest filing shown is 8-K dated Nov 12, 2026.
How many recent filings does FDMT have?
Intrinsic Alpha currently shows 20 recent filings for FDMT.
Continue the stock analysis
Jump to another research area for this company.